Support and Resistance Basics

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

ATGE


Top 10 Correlated ETFs

ATGE


Top 10 Correlated Stocks

ATGE


In the News

02:18 13 Aug 2022 ATGE

Adtalem (ATGE) Q3 Earnings & Revenue Beat, Margins Rise Y/Y

Adtalem Global Education's (ATGE) fourth-quarter fiscal 2022 results reflect benefits from Walden acquisition and cost synergies.

11:26 13 Aug 2022 ATGE

Adtalem Global Education, Inc. (ATGE) CEO Stephen Beard on Q4 2022 Results - Earnings Call Transcript

Adtalem Global Education, Inc. (NYSE:ATGE ) Q4 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Chandrika Nigam - Director, IR Stephen Beard - President, CEO & Director Robert Phelan - SVP & CFO Conference Call Participants Jeffrey Meuler - Robert W. Baird & Co. Jeffrey Silber - BMO Capital Markets Operator Greetings.

09:47 13 Aug 2022 ATGE

3 School Stocks Set to Gain Despite Industry Headwinds

Virtual delivery of education and prudent cost-saving initiatives are likely to open up opportunities for LRN, ATGE and PRDO. Fed's hawkish moves and higher costs are risks for the Zacks Schools industry.

02:18 13 Aug 2022 ATGE

Adtalem Global (ATGE) to Post Q4 Earnings: What to Expect?

More operational efficiency and realization of cost synergies associated with the Walden integration should aid Adtalem Global Education's (ATGE) fiscal Q4 earnings.

04:05 13 Aug 2022 ATGE

Adtalem Global Education Announces Fiscal Fourth Quarter and Full Year 2022 Conference Call

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), a leading healthcare educator, announced today it will hold a conference call to discuss its fiscal 2022 fourth quarter and full year results on Thursday, Aug. 11, 2022, at 4 p.m. CT (5 p.m. EDT). The conference call will be led by Steve Beard, president and chief executive officer, and Bob Phelan, senior vice president and chief financial officer. For those participating by telephone, dial 877-407-6184 (United States) or +1

01:01 13 Aug 2022 ATGE

3 Education Stocks to Enroll in This Summer

With so many companies competing to reach the head of the class, choosing winning education stocks is a brain teaser. When it comes to good long-term growth prospects, these three names make the grade.

02:37 13 Aug 2022 ATGE

Adtalem (ATGE) Up 17.4% in Last 6 Months: Factors to Note

Adtalem (ATGE) benefits from solid demand for healthcare programs and offerings.

09:47 13 Aug 2022 ATGE

Top 5 Consumer Discretionary Picks Defying Sector's Bloodbath

We have narrowed our search to five consumer discretionary stocks that have popped with double-digit returns year to date. These are: HRB, MAT, NXST, LRN and ATGE.

01:33 13 Aug 2022 ATGE

Can Adtalem (ATGE) Run Higher on Rising Earnings Estimates?

Adtalem (ATGE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

03:00 13 Aug 2022 ATGE

3 Online Education Stocks Investors Should Study

A study conducted by Global Market Insights (GMI) concluded that the global e-learning market will grow 20% annually over the next seven years and cross the $1 trillion mark by 2028. Gaining knowledge about which stocks to buy should involve studying these three companies.

Financial details

Company Rating
Buy
Market Cap
1.73B
Income
318.7M
Revenue
1.37B
Book val./share
30.48
Cash/share
16.12
Dividend
-
Dividend %
-
Employees
10K
Optionable
No
Shortable
Yes
Earnings
01 Nov 2022
P/E
1252.33
Forward P/E
8.8
PEG
-24.55
P/S
1.17
P/B
1.13
P/C
2.33
P/FCF
-82.25
Quick Ratio
1.03
Current Ratio
1.33
Debt / Equity
0.95
LT Debt / Equity
0.95
-
-
EPS (TTM)
6.52
EPS next Y
4.27
EPS next Q
0.95
EPS this Y
-194.34%
EPS next Y
-34.59%
EPS next 5Y
-34.59%
EPS last 5Y
-4.92%
Revenue last 5Y
-9.28%
Revenue Q/Q
-1.5%
EPS Q/Q
1886.11%
-
-
-
-
SMA20
3.17%
SMA50
20.11%
SMA100
42.82%
Inst Own
96.23%
Inst Trans
-3.77%
ROA
10%
ROE
23%
ROC
0.04%
Gross Margin
34%
Oper. Margin
7%
Profit Margin
22%
Payout
-
Shs Outstand
45.14M
Shs Float
43.6M
-
-
-
-
Target Price
-
52W Range
19.14-40.6
52W High
-6.08%
52W Low
+97.74%
RSI
44.96
Rel Volume
1.56
Avg Volume
480.74K
Volume
748.62K
Perf Week
-5.86%
Perf Month
4.45%
Perf Quarter
80.36%
Perf Half Y
52.11%
-
-
-
-
Beta
0.993188
-
-
Volatility
0.58%, 1.13%
Prev Close
-0.45%
Price
37.57
Change
-3.69%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-06-30

Metric History 2017-06-302018-06-302019-06-302020-06-30 2021-06-30
Revenue per share
28.5620.0521.2319.6121.67
Net income per share
1.930.551.63-1.591.5
Operating cash flow per share
3.63.93.512.013.74
Free cash flow per share
2.822.812.41.182.8
Cash per share
3.887.085.289.499.64
Book value per share
26.3424.7423.8324.4225.35
Tangible book value per share
6.385.581.76.276.59
Share holders equity per share
26.3424.7423.8324.4225.35
Interest debt per share
2.125.017.279.9926.02
Market cap
2.09B3.36B2.86B1.87B1.87B
Enterprise value
1.97B3.22B2.96B1.88B2.66B
P/E ratio
17.0799.5530.04-21.8624.25
Price to sales ratio
1.152.732.311.771.68
POCF ratio
9.1614.0513.9617.329.7
PFCF ratio
11.6619.4720.4129.3612.99
P/B Ratio
1.252.212.051.421.43
PTB ratio
1.252.212.051.421.43
EV to sales
1.092.622.391.792.4
Enterprise value over EBITDA
8.7217.414.4665.3710.98
EV to operating cash flow
8.6413.4814.4517.4813.86
EV to free cash flow
11.0118.6721.1329.6118.56
Earnings yield
0.060.010.03-0.050.04
Free cash flow yield
0.090.050.050.030.08
Debt to equity
0.070.190.290.350.95
Debt to assets
0.280.350.380.410.57
Net debt to EBITDA
-0.52-0.740.50.573.3
Current ratio
1.251.881.6223.71
Interest coverage
15.1614.197.877.293.9
Income quality
1.867.082.15-1.262.5
Dividend Yield
0.010000
Payout ratio
0.090000
Sales general and administrative to revenue
0.340.30.3200
Research and developement to revenue
00000
Intangibles to total assets
0.550.50.580.440.32
Capex to operating cash flow
-0.21-0.28-0.32-0.41-0.25
Capex to revenue
-0.03-0.05-0.05-0.04-0.04
Capex to depreciation
-0.58-1.26-1.25-0.44-0.49
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
33.8217.529.5729.5629.24
ROIC
0.070.10.10.080.06
Return on tangible assets
0.120.030.1-0.070.04
Graham Net
-4.25-4.57-7.27-6.4-23.52
Working capital
93.88M322.22M193.07M346.78M1.11B
Tangible asset value
403.95M342.47M98.98M336.69M338.45M
Net current asset value
-173.79M-137.68M-346.47M-225.5M-237.81M
Invested capital
0.070.190.290.390.99
Average receivables
130.2M116.88M122.44M87.04M77.52M
Average payables
55.38M46.98M52.06M46.48M51.28M
Average inventory
00000
Days sales outstanding
34.9643.546.4730.222.31
Days payables outstanding
24.3926.8433.7334.6241.83
Days of inventory on hand
00000
Receivables turnover
10.448.397.8512.0916.36
Payables turnover
14.9713.610.8210.548.73
Inventory turnover
00000
ROE
0.070.020.07-0.070.06
Capex per share
-0.77-1.08-1.11-0.82-0.95

Quarterly Fundamentals Overview

Last date of statement is 2022-03-31 for Q3

Metric History 2021-03-312021-06-302021-09-302021-12-31 2022-03-31
Revenue per share
5.545.627.017.467.47
Net income per share
0.490.18-1.170.367.15
Operating cash flow per share
1.590.960.82-0.381.03
Free cash flow per share
1.380.690.68-0.680.88
Cash per share
10.049.927.255.5316.12
Book value per share
25.7926.0825.4825.8730.48
Tangible book value per share
6.716.78-23.24-11.94-7.5
Share holders equity per share
25.7926.0825.4825.8730.48
Interest debt per share
25.6326.4537.2741.1830.45
Market cap
2B1.78B1.88B1.47B1.45B
Enterprise value
2.8B2.58B3.35B3.27B2.13B
P/E ratio
20.3149.32-8.0920.61.04
Price to sales ratio
7.146.345.393.963.98
POCF ratio
24.837.0145.95-77.5728.85
PFCF ratio
28.5751.9655.99-43.6133.87
P/B Ratio
1.531.371.481.140.97
PTB ratio
1.531.371.481.140.97
EV to sales
9.969.199.618.815.83
Enterprise value over EBITDA
42.7241.74-1.09K42.035.14
EV to operating cash flow
34.6153.6581.88-172.4842.28
EV to free cash flow
39.8775.3299.76-96.9749.65
Earnings yield
0.010.01-0.030.010.24
Free cash flow yield
0.030.020.02-0.020.03
Debt to equity
0.940.951.391.480.95
Debt to assets
0.570.570.660.650.58
Net debt to EBITDA
12.1112.95-477.1623.131.63
Current ratio
3.923.711.121.231.94
Interest coverage
5.171.59-0.21-0.951.38
Income quality
3.285.33-0.7-1.060.14
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.320.320.640.510.53
Capex to operating cash flow
-0.13-0.29-0.180.78-0.15
Capex to revenue
-0.04-0.05-0.02-0.04-0.02
Capex to depreciation
-0.43-0.58-0.17-0.32-0.15
Stock based compensation to revenue
0.010.010.030.040.01
Graham number
16.810.325.8714.4570.03
ROIC
0.020.0200.010.01
Return on tangible assets
0.010-0.040.010.21
Graham Net
-22.86-24.2-40.68-40.68-23.84
Working capital
1.12B1.11B73.56M113.03M489.79M
Tangible asset value
339.69M338.45M-1.15B-594.08M-366.84M
Net current asset value
-227.5M-237.81M-1.79B-1.76B-1.02B
Invested capital
0.990.991.451.610.98
Average receivables
85.15M80.37M127.98M92.74M94.4M
Average payables
55.69M60.75M89.5M65.42M66.34M
Average inventory
00000
Days sales outstanding
24.8721.8342.1722.4923.65
Days payables outstanding
33.6140.1762.6717.6336.46
Days of inventory on hand
00000
Receivables turnover
3.624.122.1343.81
Payables turnover
2.682.241.445.112.47
Inventory turnover
00000
ROE
0.020.01-0.050.010.23
Capex per share
-0.21-0.28-0.15-0.3-0.15

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap